Table 6. Top canonical pathways affected by up-regulated genes/isoforms after thrombin treatment of HMVEC cells.
Up regulated genes | ||
Canonical Pathway | p value | Genes |
Role of IL-17A in Psoriasis | 0.000 | 23% |
Differential Regulation of Cytokine Production in Macrophages and T Helper Cells by IL-17A and IL-17F | 0.000 | 22% |
TREM1 Signaling | 0.000 | 19% |
Role of Cytokines in Mediating Communication between Immune Cells | 0.000 | 13% |
Role of IL-17F in Allergic Inflammatory Airway Diseases | 0.000 | 13% |
Top canonical pathways significantly up-regulated by thrombin treatment as determined by Ingenuity Pathway Analysis. Pathways with a p-value less than 0.05 defined as significant.